Inventor

Li Sun

Inventor

Foster City, CA, US

Overview

1997–2017

Patent span

Chemistry

Primary field (CPC C)

Patents· 58 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds48%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%

A61KPreparations for medical, dental or toiletry purposes8%

C07KPeptides7%

C07CAcyclic or carbocyclic compounds3%

G06FElectric digital data processing3%

C12NMicroorganisms or enzymes2%

PatentTitleYear

9,840,536'Methods and compositions for the treatment of gastrointestinal disorders'2017 8,101,579'Methods and compositions for the treatment of gastrointestinal disorders'2012 7,910,546'Methods and compositions for the treatment of gastrointestinal disorders'2011 7,772,188'Methods and compositions for the treatment of gastrointestinal disorders'2010 7,582,756'3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors'2009 7,494,979'Method for treating congestive heart failure and other disorders'2009 7,371,727'Methods and compositions for the treatment of gastrointestinal disorders'2008 7,304,084'6-[(4,5-Dihydro-1H-imidazol-2-yl)amino]-7-methyl-1H-benzimidazole-4-carbonitrile and its preferred salt'2007 7,256,189'3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone der derivatives as protein kinase inhibitors'2007 7,189,721'Bicyclic protein kinase inhibitors'2007 7,179,910'3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors'2007 7,125,905'Pyrrole substituted 2-indolinone protein kinase inhibitors'2006 7,119,090'Pyrrole substituted 2-indolinone protein kinase inhibitors'2006 6,987,113'Tyrosine kinase inhibitors'2006 6,908,930'4-substituted 7-AZA-indolin-2-ones and their use as protein kinase inhibitors'2005 6,906,093'Indolinone combinatorial libraries and related products and methods for the treatment of disease'2005 6,855,730'3-methylidenyl-2-indolinone modulators of protein kinase'2005 6,849,641'Azaindole tyrosine kinase inhibitors'2005 6,846,839'Methods for treating diseases and disorders related to unregulated angiogenesis and/or vasculogenesis'2005 6,696,463'3-heteroarylidenyl-2-azaindolinones active as protein tyrosine kinase inhibitors'2004 6,696,448'3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors'2004 6,689,806'Indolinone compounds as kinase inhibitors'2004 6,683,082'Bicyclic protein kinase inhibitors'2004 6,656,940'Tricyclic quinoxaline derivatives as protein tyrosine kinase inhibitors'2003 6,653,308'3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors'2003 6,642,251'Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity'2003 6,610,688'4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors'2003 6,579,897'3-(cycloalkanoheteroarylidenyl)-2-indolinone protein tyrosine kinase inhibitors'2003 6,573,293'Pyrrole substituted 2-indolinone protein kinase inhibitors'2003 6,569,868'2-indolinone derivatives as modulators of protein kinase activity'2003 6,531,502'3-Methylidenyl-2-indolinone modulators of protein kinase'2003 6,525,072'Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity'2003 6,514,981'Methods of modulating tyrosine protein kinase function with indolinone compounds'2003 6,506,763'3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity'2003 6,486,185'3-heteroarylidene-2-indolinone protein kinase inhibitors'2002 6,469,032'3-(4-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease'2002 6,395,734'Pyrrole substituted 2-indolinone protein kinase inhibitors'2002 6,350,754'3-(cycloalkanoheteroarylidenyl)-2-indolinone protein tyrosine kinase inhibitors'2002 6,329,375'Tricyclic quinoxaline derivatives as protein tyrosine kinase inhibitors'2001 6,316,635'2-indolinone derivatives as modulators of protein kinase activity'2001 6,316,429'Bicyclic protein kinase inhibitors'2001 6,313,158'Bioavailability of 3-heteroarylidenyl-2-indolinones active as protein tyrosine kinase inhibitors'2001 6,225,346'Tyrphostin like compounds'2001 6,225,335'3-(4\'-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease'2001 6,147,106'Indolinone combinatorial libraries and related products and methods for the treatment of disease'2000 6,133,305'3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity'2000 6,130,238'3-(cyclohexanoheteroarylidenyl)-2-indolinone protein tyrosine kinase inhibitors'2000 6,114,371'3-(cyclohexanoheteroarylidenyl)-2-indolinone protein tyrosine kinase inhibitors'2000 6,051,593'3-(cycloalkanoheteroarylidenyl)-2- indolinone protein tyrosine kinase inhibitors'2000 5,935,993'Tyrphostin like compounds'1999 5,891,917'Certain acrylonitrile-sulfonamide derivatives'1999 5,886,020'3-(4\'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease'1999 5,883,113'3-(4\'-Bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease'1999 5,883,116'3-(2\'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease'1999 5,880,141'Benzylidene-Z-indoline compounds for the treatment of disease'1999 5,834,504'3-(2\'-halobenzylidenyl)-2-indolinone compounds for the treatment of disease'1998 5,792,783'3-heteroaryl-2-indolinone compounds for the treatment of disease'1998 5,650,415'Quinoline compounds'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–2009Patents assigned to SUGEN INC (49)· patent assignee history

1997–2009Based in Foster City, CA, US· patent location history

2003–2009Patents assigned to UPJOHN CO (5)· patent assignee history

2004Based in Forest City, CA, US· patent location history

2007Patents assigned to AGOURON PHARMA (1)· patent assignee history

2007Based in Grays Lake, IL, US· patent location history

2008–2017Based in New York, NY, US· patent location history

2009–2017Patents assigned to IRONWOOD PHARMACEUTICALS INC (5)· patent assignee history

2012Patents assigned to CURRIE MARK G (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
SUGEN INC	49	1997–2009
IRONWOOD PHARMACEUTICALS INC	5	2009–2017
UPJOHN CO	5	2003–2009
AGOURON PHARMA	1	2007
CURRIE MARK G	1	2012

Locations

Location	Patents	Span
Foster City, California, US	50	1997–2009
New York, New York, US	6	2008–2017
Grays Lake, Illinois, US	1	2007
Forest City, California, US	1	2004